BT-11

DRUG2 trials

Sponsors

NImmune Biopharma

Conditions

Crohn's DiseaseNormal Healthy Volunteers

Phase 1

Safety, Tolerability, and Pharmacokinetics of Oral BT-11 in Healthy Adult Male and Female Volunteers

CompletedNCT03860571

NImmune BiopharmaNormal Healthy Volunteers

Start: 2018-07-06End: 2018-12-13Updated: 2023-06-07

Phase 2

Safety and Efficacy of Oral BT-11 in Crohn's Disease Patients With Moderate to Severe Disease

WithdrawnNCT05057273

NImmune BiopharmaCrohn's Disease

Start: 2021-11-30End: 2022-02-28Updated: 2023-06-07